<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ABVC
ABVC BioPharma
$
()


  • ABVC BioPharma enters into global licensing deal with ForSeeCon Eye

    3/26/2024 - 08:35am
  • AiBtl BioPharma completes $7.6M land deal

    3/21/2024 - 08:40am
  • ABVC BioPharma provides update on development of combination therapy

    2/27/2024 - 08:43am
  • ABVC enters agreement to license certain healthcare-related expertise to SPI

    2/15/2024 - 08:39am
  • ABVC BioPharma receives Australian patent for treatment of MDD

    2/12/2024 - 08:35am
  • ABVC BioPharma acquires $2.96M worth of land in Asia

    2/8/2024 - 09:18am
  • ABVC BioPharma files to sell 10.4M shares of common stock for holders

    1/12/2024 - 17:04pm
  • ABVC BioPharma, BioLite receive $460M milestone payment from AiBtl

    1/3/2024 - 07:27am
  • ABVC BioPharma completes subject treatment in ADHD Phase IIb study

    12/7/2023 - 08:33am
  • ABVC BioPharma receives U.S. patent for ADHD treatment

    11/21/2023 - 08:34am
  • ABVC BioPharma enters global licensing agreement with AiBtl BioPharma

    11/16/2023 - 10:08am
  • ABVC BioPharma reports Q3 EPS (82c) vs ($1.14) last year

    11/15/2023 - 09:04am
  • ABVC BioPharma enters into term sheet to license global rights of CNS drugs

    10/26/2023 - 08:37am
  • ABVC BioPharma announces update for ADHD Phase IIb study

    10/17/2023 - 08:39am
  • ABVC BioPharma receives Taiwanese patent for MDD treatment

    10/9/2023 - 08:38am
dynamic_feed Breaking News